Pharma
Pharma business division consists of General Medicines & Oncology.
General Medicines
The Pharmaceuticals Division of Novartis is recognised worldwide for the innovative medicines we provide to patients, physicians and healthcare organisations.
This business develops and markets innovative prescription drugs for important health needs. We provide medicines to treat and prevent diseases, ease suffering and improve quality of life. Our products are concentrated in the following therapeutic areas.
- Cardiovascular and metabolic diseases
- Neuroscience
- Metabolic bone disease
- Transplantation
- Ophthalmics
- Respiratory disease
- Pain management
- Other – Mature product portfolio
Oncology
Our strong oncology portfolio provides cancer patients with a broad range of innovative therapies and practical solutions. Our efforts to discover and develop innovative approaches for the treatment of cancer have produced breakthrough medicines for chronic myeloid leukemia, gastrointestinal stromal tumours (GIST), breast cancer and bone cancer. We also have treatment for acromegaly, a disorder caused by overproduction of growth hormone, and treatment for chronic iron overload in transfusion-related conditions.